Renaissance Technologies LLC lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 37.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 383,353 shares of the medical instruments supplier's stock after selling 226,605 shares during the period. Renaissance Technologies LLC owned approximately 0.19% of DENTSPLY SIRONA worth $7,276,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Riverview Trust Co acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 1,568 shares during the period. Finally, Signaturefd LLC boosted its holdings in DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.52% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently issued reports on the stock. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Mizuho reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Thirteen analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of "Hold" and an average price target of $22.58.
Read Our Latest Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Up 2.5 %
NASDAQ XRAY traded up $0.34 on Thursday, hitting $13.62. 441,255 shares of the company were exchanged, compared to its average volume of 2,949,603. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $31.00. The firm has a market capitalization of $2.71 billion, a P/E ratio of -6.57, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company's 50 day moving average price is $15.28 and its 200-day moving average price is $18.48.
DENTSPLY SIRONA Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.70%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.